Kyowa Hakko Kirin
|
2,166.50 |
|
18.00 |
0.84% |
-18.40% |
2025-04-15 |
Astellas Pharma
|
1,338.00 |
|
25.00 |
1.90% |
-7.72% |
2025-04-15 |
AbbVie
|
179.08 |
|
4.20 |
2.40% |
10.79% |
2025-04-14 |
Agios Pharmaceuticals
|
27.52 |
|
0.82 |
3.07% |
-5.95% |
2025-04-14 |
Alnylam Pharmaceuticals
|
240.18 |
|
2.41 |
1.01% |
62.61% |
2025-04-14 |
Amgen
|
293.70 |
|
7.83 |
2.74% |
10.59% |
2025-04-14 |
AstraZeneca
|
10,320.00 |
|
312.00 |
3.12% |
-6.39% |
2025-04-14 |
Biogen
|
119.22 |
|
4.07 |
3.53% |
-39.44% |
2025-04-14 |
BioMarin Pharmaceutical
|
59.67 |
|
2.85 |
5.02% |
-34.79% |
2025-04-14 |
Bristol-Myers Squibb
|
51.35 |
|
0.68 |
1.34% |
5.70% |
2025-04-14 |
Gilead Sciences
|
106.50 |
|
2.92 |
2.82% |
57.10% |
2025-04-14 |
GlaxoSmithKline
|
1,322.50 |
|
28.50 |
2.20% |
-19.53% |
2025-04-14 |
Incyte
|
59.22 |
|
2.35 |
4.13% |
10.84% |
2025-04-14 |
Ionis Pharmaceuticals
|
28.68 |
|
0.78 |
2.80% |
-30.97% |
2025-04-14 |
J&J
|
154.24 |
|
2.65 |
1.75% |
4.47% |
2025-04-14 |
Eli Lilly
|
753.80 |
|
21.97 |
3.00% |
0.34% |
2025-04-14 |
Merck
|
79.03 |
|
-0.11 |
-0.14% |
-37.37% |
2025-04-14 |
Moderna
|
26.81 |
|
0.64 |
2.45% |
-74.20% |
2025-04-14 |
Neurocrine Biosciences
|
94.86 |
|
3.99 |
4.39% |
-27.99% |
2025-04-14 |
Novartis
|
88.74 |
|
2.65 |
3.08% |
2.59% |
2025-04-14 |
Novartis
|
109.48 |
|
5.65 |
5.44% |
16.96% |
2025-04-14 |
Pfizer
|
22.09 |
|
0.20 |
0.91% |
-14.71% |
2025-04-14 |
Ultragenyx Pharmaceutical
|
34.92 |
|
0.78 |
2.28% |
-18.54% |
2025-04-14 |
Regeneron Pharmaceuticals
|
570.58 |
|
16.82 |
3.04% |
-36.49% |
2025-04-14 |
Roche Holding
|
251.70 |
|
7.90 |
3.24% |
11.82% |
2025-04-14 |
Sanofi
|
51.84 |
|
2.13 |
4.27% |
12.88% |
2025-04-14 |
Sarepta Therapeutics
|
54.63 |
|
3.60 |
7.05% |
-53.82% |
2025-04-14 |
Teva Pharmaceutical Industries
|
5,060.00 |
|
51.00 |
1.02% |
1.61% |
2025-04-14 |
United Therapeutics
|
284.31 |
|
3.15 |
1.12% |
20.94% |
2025-04-14 |
Vertex Pharmaceuticals
|
495.91 |
|
11.89 |
2.46% |
24.76% |
2025-04-14 |